keyword
https://read.qxmd.com/read/38645090/a-single-cell-atlas-of-the-mouse-seminal-vesicle
#1
Fengyun Sun, Kathleen Desevin, Yu Fu, Shanmathi Parameswaran, Jemma Mayall, Vera Rinaldi, Nils Krietenstein, Artur Manukyan, Qiangzong Yin, Carolina Galan, Chih-Hsiang Yang, Anastasia V Shindyapina, Vadim N Gladyshev, Manuel Garber, John E Schjenken, Oliver J Rando
During mammalian reproduction, sperm are delivered to the female reproductive tract bathed in a complex medium known as seminal fluid, which plays key roles in signaling to the female reproductive tract and in nourishing sperm for their onwards journey. Along with minor contributions from the prostate and the epididymis, the majority of seminal fluid is produced by a somewhat understudied organ known as the seminal vesicle. Here, we report the first single-cell RNA-seq atlas of the mouse seminal vesicle, generated using tissues obtained from 23 mice of varying ages, exposed to a range of dietary challenges...
April 11, 2024: bioRxiv
https://read.qxmd.com/read/38643073/advanced-in-immunological-monitoring-of-hiv-infection-profile-of-immune-cells-and-cytokines-in-people-living-with-hiv-1-in-benin
#2
JOURNAL ARTICLE
Yaou Pierrot Assogba, Adefounke Prudencia Adechina, Edmond Tchiakpe, Odilon Paterne Nouatin, René K Kèkè, Moussa Bachabi, Honoré Sourou Bankole, Akadiri Yessoufou
BACKGROUND: Immune cells and cytokines have been linked to viremia dynamic and immune status during HIV infection. They may serve as useful biomarkers in the monitoring of people living with HIV-1 (PLHIV-1). The present work was aimed to assess whether cytokines and immune cell profiles may help in the therapeutic follow-up of PLHIV-1. METHODS: Forty PLHIV-1 in treatment success (PLHIV-1s) and fifty PLHIV-1 in treatment failure (PLHIV-1f) followed at the University Hospital of Abomey-Calavi/Sô-Ava in Benin were enrolled...
April 20, 2024: BMC Immunology
https://read.qxmd.com/read/38642109/a-phase-i-trial-of-autologous-rak-cell-immunotherapy-in-metastatic-renal-cell-carcinoma
#3
JOURNAL ARTICLE
Jing Xu, Wen Zhang, Jinlian Tong, Caixia Liu, Qiaohui Zhang, Liren Cao, Jiangyong Yu, Aiping Zhou, Jie Ma
BACKGROUND: Treatment of metastatic renal cell carcinoma (mRCC) remains a challenge worldwide. Here, we introduced a phase I trial of autologous RAK cell therapy in patients with mRCC whose cancers progressed after prior systemic therapy. Although RAK cells have been used in clinic for many years, there has been no dose-escalation study to demonstrate its safety and efficacy. METHODS: We conducted a phase I trial with a 3 + 3 dose-escalation design to investigate the dose-related safety and efficacy of RAK cells in patients with mRCC whose cancers have failed to response to systemic therapy (ChiCTR1900021334)...
April 20, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38642003/a-case-of-excisionally-remitted-indolent-nk-cell-enteropathy-in-the-oral-cavity-and-a-mini-review
#4
Xiangyun Li, Zhu Li, Xiaoge Zhou, Yuanyuan Zheng, Yanlin Zhang, Jianlan Xie
Benign natural killer cell enteropathy (NKCE) was first identified in the gastrointestinal (GI) tract. Notably, instances of NKCE have previously been observed at various sites other than the GI tract, including the gallbladder, lymph nodes, esophagus, and female genital tract. Typical NKCE manifests as an NK-cell immunohistological phenotype, with or without TCR rearrangement, and is characterized by the absence of Epstein-Barr virus (EBV) infection and protracted clinical progression. The misdiagnosis of NKT-cell lymphoma has resulted in some patients receiving chemotherapy, while in other instances, the patients' conditions resolved without treatment and showed no evidence of disease recurrence or progression during follow-up examinations...
April 20, 2024: Journal of Cutaneous Pathology
https://read.qxmd.com/read/38641608/revealing-prdx4-as-a-potential-diagnostic-and-therapeutic-target-for-acute-pancreatitis-based-on-machine-learning-analysis
#5
JOURNAL ARTICLE
Zhonghua Lu, Yan Tang, Ruxue Qin, Ziyu Han, Hu Chen, Lijun Cao, Pinjie Zhang, Xiang Yang, Weili Yu, Na Cheng, Yun Sun
Acute pancreatitis (AP) is a common systemic inflammatory disease resulting from the activation of trypsinogen by various incentives in ICU. The annual incidence rate is approximately 30 out of 100,000. Some patients may progress to severe acute pancreatitis, with a mortality rate of up to 40%. Therefore, the goal of this article is to explore the key genes for effective diagnosis and treatment of AP. The analysis data for this study were merged from two GEO datasets. 1357 DEGs were used for functional enrichment and cMAP analysis, aiming to reveal the pathogenic genes and potential mechanisms of AP, as well as potential drugs for treating AP...
April 19, 2024: BMC Medical Genomics
https://read.qxmd.com/read/38638438/enrichment-of-type-1-innate-lymphoid-cells-in-the-course-of-human-atherosclerotic-plaque-development-suggests-contribution-to-atherogenesis
#6
JOURNAL ARTICLE
Kartika R Pertiwi, Marcel B M Teunissen, Gabrielle Krebbers, Martine C M Willems, Laurens Huisman, Cindy Poelen, Allard C van der Wal, Onno J de Boer
INTRODUCTION: Innate lymphoid cells (ILCs) have been implicated in multiple pathologic conditions, including atherogenesis, as documented in experimental mice studies, however, their role in atherosclerosis in humans remains unexplored. METHODS: Here, we identify ILCs and their dynamics in early, advanced, and complicated human carotid- and aortic atherosclerotic plaques, using a multiplex immunohistochemical quadruple-staining technique with prototypic transcription factors T-bet, GATA3, or RORgt for identification of the ILC1, ILC2 and ILC3 subsets, respectively, in combination with lineage markers CD3, CD20/ CD79a and CD56 to exclude other lymphoid cell types...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38637967/effector-function-characteristics-of-exhausted-cd8-t-cell-in-microsatellite-stable-and-unstable-gastric-cancer
#7
JOURNAL ARTICLE
Dong-Seok Han, Yoonjin Kwak, Seungho Lee, Soo Kyung Nam, Seong-Ho Kong, Do Joong Park, Hyuk-Joon Lee, Nak-Jung Kwon, Hye Seung Lee, Han-Kwang Yang
PURPOSE: Gastric cancer exhibits molecular heterogeneity, with the microsatellite instability high (MSI-H) subtype drawing attention for its distinct features. Despite a higher survival rate, MSI-H gastric cancer lack significant benefits from conventional chemotherapy. The immune checkpoint inhibitors (ICIs), presents a potential avenue, but a deeper understanding of the tumor immune microenvironment of MSI-H gastric cancer is essential. MATERIALS AND METHODS: We explored the molecular characteristics of CD8+ T cell subtypes in three MSI-H and three microsatellite stable (MSS) gastric cancer samples using single-cell RNA sequencing and spatial transcriptome analysis...
April 12, 2024: Cancer Research and Treatment: Official Journal of Korean Cancer Association
https://read.qxmd.com/read/38629075/natural-killer-t-cells-in-allergic-asthma-implications-for-the-development-of-novel-immunotherapeutical-strategies
#8
REVIEW
Cristián Gutiérrez-Vera, Richard García-Betancourt, Pablo A Palacios, Marioly Müller, David A Montero, Carlos Verdugo, Francisca Ortiz, Felipe Simon, Alexis M Kalergis, Pablo A González, Noemi A Saavedra-Avila, Steven A Porcelli, Leandro J Carreño
Allergic asthma has emerged as a prevalent allergic disease worldwide, affecting most prominently both young individuals and lower-income populations in developing and developed countries. To devise effective and curative immunotherapy, it is crucial to comprehend the intricate nature of this condition, characterized by an immune response imbalance that favors a proinflammatory profile orchestrated by diverse subsets of immune cells. Although the involvement of Natural Killer T (NKT) cells in asthma pathology is frequently implied, their specific contributions to disease onset and progression remain incompletely understood...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38622654/immunotherapy-with-an-antibody-against-cd1d-modulates-neuroinflammation-in-an-%C3%AE-synuclein-transgenic-model-of-lewy-body-like-disease
#9
JOURNAL ARTICLE
Michiyo Iba, Somin Kwon, Changyoun Kim, Marcell Szabo, Liam Horan-Portelance, Maria Lopez-Ocasio, Pradeep Dagur, Cassia Overk, Robert A Rissman, Eliezer Masliah
The neuroinflammatory process in synucleinopathies of the aging population such as Parkinson's disease (PD) and dementia with Lewy bodies (DLB) involves microglial activation as well as infiltration of the CNS by T cells and natural killer T cells (NKTs). To evaluate the potential of targeting NKT cells to modulate neuroinflammation, we treated α-syn transgenic (tg) mice (e.g.: Thy1 promoter line 61) with an antibody against CD1d, which is a glycoprotein expressed in antigen presenting cells (APCs). CD1d-presented lipid antigens activate NKT cells through the interaction with T cell receptor in NKTs, resulting in the production of cytokines...
April 15, 2024: Journal of Neuroinflammation
https://read.qxmd.com/read/38612827/slam-family-receptors-in-b-cell-chronic-lymphoproliferative-disorders
#10
REVIEW
Dominik Kľoc, Slavomír Kurhajec, Mykhailo Huniadi, Ján Sýkora, Tomáš Guman, Marek Šarišský
The signaling lymphocytic activation molecule (SLAM) receptor family (SLAMF) consists of nine glycoproteins that belong to the CD2 superfamily of immunoglobulin (Ig) domain-containing molecules. SLAMF receptors modulate the differentiation and activation of a wide range of immune cells. Individual SLAMF receptors are expressed on the surface of hematopoietic stem cells, hematopoietic progenitor cells, B cells, T cells, NK cells, NKT cells, monocytes, macrophages, dendritic cells, neutrophils, and platelets...
April 4, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38586879/ox-ldl-induced-cd80-macrophages-expand-pro-atherosclerotic-nkt-cells-via-cd1d-in-atherosclerotic-mice-and-hyperlipidemic-patients
#11
JOURNAL ARTICLE
Yin Wang, Yao Zou, Qingsong Jiang, Wenming Li, Xinyu Chai, Tingrui Zhao, Siyi Liu, Zhiyi Yuan, Chao Yu, Tingting Wang
Atherosclerosis is an inflammatory disease of blood vessels involving the immune system. Natural killer T (NKT) cells, as crucial components of the innate and acquired immune systems, play critical roles in the development of atherosclerosis. However, the mechanism and clinical relevance of NKT cells in early atherosclerosis are largely unclear. Our findings demonstrated that there were higher populations of NKT cells and interferon gamma (IFN-γ)-producing NKT cells in the peripheral blood of patients with hyperlipidemia and in the aorta, blood, spleen, and bone marrow of early atherosclerotic mice compared to control groups...
April 8, 2024: American Journal of Physiology. Cell Physiology
https://read.qxmd.com/read/38584391/engineering-allorejection-resistant-car-nkt-cells-from-hematopoietic-stem-cells-for-off-the-shelf-cancer-immunotherapy
#12
JOURNAL ARTICLE
Yan-Ruide Li, Yang Zhou, Jiaji Yu, Yichen Zhu, Derek Lee, Enbo Zhu, Zhe Li, Yu Jeong Kim, Kuangyi Zhou, Ying Fang, Zibai Lyu, Yuning Chen, Yanxin Tian, Jie Huang, Xinjian Cen, Tiffany Husman, Jae Min Cho, Tzung Hsiai, Jin J Zhou, Pin Wang, Benjamin R Puliafito, Sarah M Larson, Lili Yang
The clinical potential of current FDA-approved chimeric antigen receptor (CAR)-engineered T (CAR-T) cell therapy is encumbered by its autologous nature, which presents notable challenges related to manufacturing complexities, heightened costs, and limitations in patient selection. Therefore, there is a growing demand for off-the-shelf universal cell therapies. In this study, we have generated universal CAR-engineered NKT (U CAR-NKT) cells by integrating iNKT TCR engineering and HLA gene editing on HSCs, along with an ex vivo, feeder-free HSC differentiation culture...
April 6, 2024: Molecular Therapy
https://read.qxmd.com/read/38562778/the-clcf1-cntfr-axis-drives-an-immunosuppressive-tumor-microenvironment-and-blockade-enhances-the-effects-of-established-cancer-therapies
#13
Eric Sweet-Cordero, Kieren Marini, Emma Champion, Alex Lee, Isabelle Young, Stanley Leung, Nicolas Mathey-Andrews, Tyler Jacks, Peter Jackson, Jennifer Cochran
Tumors comprise a complex ecosystem consisting of many cell types that communicate through secreted factors. Targeting these intercellular signaling networks remains an important challenge in cancer research. Cardiotrophin-like cytokine factor 1 (CLCF1) is an interleukin-6 (IL-6) family member secreted by cancer-associated fibroblasts (CAFs) that binds to ciliary neurotrophic factor receptor (CNTFR), promoting tumor growth in lung and liver cancer 1,2 . A high-affinity soluble receptor (eCNTFR-Fc) that sequesters CLCF1 has anti-oncogenic effects 3 ...
March 22, 2024: Research Square
https://read.qxmd.com/read/38558822/discovering-single-cannabidiol-or-synergistic-antitumor-effects-of-cannabidiol-and-cytokine-induced-killer-cells-on-non-small-cell-lung-cancer-cells
#14
JOURNAL ARTICLE
Yutao Li, Amit Sharma, Michèle J Hoffmann, Dirk Skowasch, Markus Essler, Hans Weiher, Ingo G H Schmidt-Wolf
INTRODUCTION: A multitude of findings from cell cultures and animal studies are available to support the anti-cancer properties of cannabidiol (CBD). Since CBD acts on multiple molecular targets, its clinical adaptation, especially in combination with cancer immunotherapy regimen remains a serious concern. METHODS: Considering this, we extensively studied the effect of CBD on the cytokine-induced killer (CIK) cell immunotherapy approach using multiple non-small cell lung cancer (NSCLC) cells harboring diverse genotypes...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38558810/gd2-targeting-therapy-a-comparative-analysis-of-approaches-and-promising-directions
#15
REVIEW
Julia Philippova, Julia Shevchenko, Sergey Sennikov
Disialoganglioside GD2 is a promising target for immunotherapy with expression primarily restricted to neuroectodermal and epithelial tumor cells. Although its role in the maintenance and repair of neural tissue is well-established, its functions during normal organism development remain understudied. Meanwhile, studies have shown that GD2 plays an important role in tumorigenesis. Its functions include proliferation, invasion, motility, and metastasis, and its high expression and ability to transform the tumor microenvironment may be associated with a malignant phenotype...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38557824/recent-advances-regarding-the-potential-roles-of-invariant-natural-killer-t-cells-in-cardiovascular-diseases-with-immunological-and-inflammatory-backgrounds
#16
JOURNAL ARTICLE
Kazuya Iwabuchi, Masashi Satoh, Kazuhisa Yoshino, Naoki Ishimori
Invariant natural killer T (iNKT) cells, which bear αβ-type T cell antigen-receptors, recognize glycolipid antigens in a cluster of differentiation 1d (CD1d)-restricted manner. Regarding these cells, the unique modes of thymic selection and maturation elucidate innateness, irrespective of them also being members of the adaptive immune system as a T cell. iNKT cells develop and differentiate into NKT1 [interferon γ (IFN-γγ-producing], NKT2 [interleukin 4 (IL-4)/IL-13-producing], or NKT17 (IL-17-producing) subsets in the thymus...
April 1, 2024: International Immunology
https://read.qxmd.com/read/38554446/strategic-development-of-a-self-adjuvanting-sars-cov-2-rbd-vaccine-from-adjuvant-screening-to-enhanced-immunogenicity-with-a-modified-tlr7-agonist
#17
JOURNAL ARTICLE
Xiongyan Meng, Ying Xu, Jing Yang, Shuai Meng, Ning Ding, Tiantian Sun, Chengli Zong
Adjuvants enhance the body's immune response to a vaccine, often leading to better protection against diseases. Monophosphoryl lipid A analogues (MPLA, TLR4 agonists), α-galactosylceramide analogues (NKT cell agonists), and imidazoquinoline compounds (TLR7/8 agonists) are emerging novel adjuvants on market or under clinical trials. Despite significant interest in these adjuvants, a direct comparison of their adjuvant activities remains unexplored. We initially assessed the activities of various adjuvants from three distinct categories using the SARS-CoV-2 RBD trimer antigen...
March 29, 2024: International Immunopharmacology
https://read.qxmd.com/read/38536025/correction-dx5-cd49b-positive-t-cells-are-not-synonymous-with-cd1d-dependent-nkt-cells
#18
Daniel G Pellicci, Kirsten J L Hammond, Jonathan Coquet, Konstantinos Kyparissoudis, Andrew G Brooks, Katherine Kedzierska, Rachael Keating, Stephen Turner, Stuart Berzins, Mark J Smyth, Dale I Godfrey
Pellicci, D. G., K. J. L. Hammond, J. Coquet, K. Kyparissoudis, A. G. Brooks, K. Kedzierska, R. Keating, S. Turner, S. Berzins, M. J. Smyth, and D. I. Godfrey. 2005. DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cells. J. Immunol. 175: 4416-4425. Fig. 2A of this article contains flow cytometry comparing C57BL/6 WT mice and CD1d-/- mice for αβTCR versus DX5 or αβTCR versus CD49b staining in mouse thymus, spleen, liver, bone marrow, and peripheral lymph nodes (PLNs)...
March 27, 2024: Journal of Immunology
https://read.qxmd.com/read/38534424/the-impact-of-cytomegalovirus-infection-on-natural-killer-and-cd8-t-cell-phenotype-in-multiple-sclerosis
#19
JOURNAL ARTICLE
Valentina Perri, Maria Antonella Zingaropoli, Patrizia Pasculli, Federica Ciccone, Matteo Tartaglia, Viola Baione, Leonardo Malimpensa, Gina Ferrazzano, Claudio Maria Mastroianni, Antonella Conte, Maria Rosa Ciardi
Multiple sclerosis (MS) is a debilitating neurological disease that has been classified as an immune-mediated attack on myelin, the protective sheath of nerves. Some aspects of its pathogenesis are still unclear; nevertheless, it is generally established that viral infections influence the course of the disease. Cytomegalovirus (CMV) is a major pathogen involved in alterations of the immune system, including the expansion of highly differentiated cytotoxic CD8+ T cells and the accumulation of adaptive natural killer (NK) cells expressing high levels of the NKG2C receptor...
February 28, 2024: Biology
https://read.qxmd.com/read/38529413/synergistic-integration-of-histone-deacetylase-inhibitors-apparently-enhances-the-cytokine-induced-killer-cell-efficiency-in-multiple-myeloma-via-the-nkg2d-pathway
#20
JOURNAL ARTICLE
Jingjing Pu, Amit Sharma, Ting Liu, Jian Hou, Ingo Gh Schmidt-Wolf
OBJECTIVES: The rapid recognition of epigenetic manipulation's potential in restricting cancer cell capabilities spurred translational initiatives, including histone deacetylase inhibitors (HDACis). Clinical trials on multiple myeloma (MM) demonstrated substantial benefits of HDACis, coupled with promising outcomes from cytokine-induced killer cell (CIK) immunotherapy. Intriguingly, the unexplored synergy of HDACis and CIK cell immunotherapy in MM prompted our study. METHODS: We examined clinically relevant HDACis (panobinostat/LBH589 and romidepsin) alongside CIK cells derived from peripheral blood mononuclear cells across diverse MM cell lines (U266, RPMI8226, OPM-2 and NCI-H929)...
2024: Clinical & Translational Immunology
keyword
keyword
362
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.